Search Results - "Mione, R."

Prognostic role of serum CA15.3 in 362 node-negative breast cancers. An old player for a new game by Gion, M., Boracchi, P., Dittadi, R., Biganzoli, E., Peloso, L., Mione, R., Gatti, C., Paccagnella, A., Marubini, E.

“…The aims of the present investigation were to evaluate the association between serum CA15.3 levels and other biological and clinical variables and its…”
Get full text

CA27.29: a valuable marker for breast cancer management. A confirmatory multicentric study on 603 cases by Gion, M, Mione, R, Leon, A.E, Lüftner, D, Molina, R, Possinger, K, Robertson, J.F

“…Recently, a fully automated method has become commercially available to measure the MUC-1-associated antigen CA27.29. The present investigation was performed…”
Get full text

P371 CONFOUNDING CARDIAC MARKERS IN A CASE OF COVID–19 MYOCARDITIS by Polo, G, Scarpa, D, Castegnaro, N, Benetti, A, Mione, R, Carraro, P

“…Abstract Background–Aim A man of 81 years, with previous coronary artery disease, unrecognized myocardial infarction, carrier of implanted pacemaker, presented…”
Get full text

The tumour associated antigen CA15.3 in primary breast cancer. Evaluation of 667 cases by GION, M, MIONE, R, NASCIMBEN, O, VALSECCHI, M, GATTI, C, LEON, A, BRUSCAGNIN, G

“…CA15.3 preoperatory serum levels have been determined in 667 patients with primary untreated breast cancer and in 193 controls. The relationships between…”
Get full text

Relationship between cathepsin D and other pathological and biological parameters in 1752 patients with primary breast cancer by Gion, M., Mione, R., Dittadi, R., Romanelli, M., Pappagallo, L., Capitanio, G., Friede, U., Barbazza, R., Visonà, A., Dante, S.

“…The relationship between cathepsin D and other pathological or biological prognostic parameters has not yet been defined through systematic studies in breast…”
Get full text

Clinical evaluation of percent free prostate-specific antigen using the AxSYM system in the best analytical scenario by Gion, M, Mione, R, Barioli, P, Barichello, M, Zattoni, F, Prayer-Galetti, T, Plebani, M, Aimo, G, Terrone, C, Manferrari, F, Madeddu, G, Caberlotto, L, Fandella, A, Pianon, C, Vianello, L, Amoroso, B

“…Percent free prostate-specific antigen (PSA) is a promising tool for prostate cancer (CaP) diagnosis. However, its diagnostic performances have not yet been…”
Get more information

PS2 in breast cancer - alternative or complementary tool to steroid receptor status? Evaluation of 446 cases by GION, M, MIONE, R, PAPPAGALLO, G. L, GATTI, C, NASCIMBEN, O, BARI, M, LEON, A. E, VINANTE, O, BRUSCAGNIN, G

“…The oestrogen induced pS2 protein was measured in the cytosol of 446 breast cancer samples by an immunoradiometric assay. The relationships between pS2 and…”
Get full text

Serum CA549 in primary breast cancer: comparison with CA15.3 and MCA by GION, M, PLEBANI, M, MIONE, R, PENZO, C, MEO, S, BURLINA, A

“…We carried out a comparison of three commonly used mucin markers, CA549, CA15.3 and MCA. Serum samples from 184 healthy women and 237 patients with primary…”
Get full text

How tumor markers are used in the routine follow-up of breast and colorectal cancer. A survey of 29 Italian hospitals by Gion, M, Barioli, P, Ponti, A, Torri, V, Mione, R, Dittadi, R

“…The impact of tumor markers on the outcome of several malignancies is still under debate. This relative uncertainty leads to a subjective approach to their…”
Get more information

How CA 125 is used in the routine follow-up of ovarian cancer: a survey of 29 Italian hospitals by Gion, M, Barioli, P, Ponti, A, Torri, V, Mione, R, Dittadi, R

“…Tumor markers are currently monitored on a routine basis. However, their impact on the course of a disease is still under debate. This relative uncertainty…”
Get more information

Impact of steroid receptors, pS2 and cathepsin D on the outcome of N+ postmenopausal breast cancer patients treated with tamoxifen by Dittadi, R, Biganzoli, E, Boracchi, P, Salbe, C, Mione, R, Gatti, C, Gion, M

“…In spite of the complexity of the biological basis of the hormonal regulation of breast cancer, clinical studies tend to simplify the information by mainly…”
Get more information

Biochemical parameters for prognostic evaluation in patients with breast cancer by Gion, M, Mione, R, Pappagallo, G L, Gatti, C, Nascimben, O, Sampognaro, E, Meo, S

“…We evaluated the prognostic value of tissue polypeptide antigen (TPA), cathepsin D and pS2 in 267 patients operated for primary breast cancer. Cathepsin D, pS2…”
Get more information

Third-generation PSA: ultrasensitive or ultraprecise assay? by Mione, R, Barichello, M, Sartorello, P, Leon, A, Barioli, P, Gion, M

“…The ultrasensitive PSA assay has been recently acknowledged as a useful tool for the monitoring of patients prostatectomized for prostatic cancer. We have…”
Get more information

Prostate cancer probability after total PSA and percent free PSA determination by Mione, R, Barioli, P, Barichello, M, Zattoni, F, Prayer-Galetti, T, Plebani, M, Aimo, G, Terrone, C, Manferrari, F, Madeddu, G, Caberlotto, L, Fandella, A, Pianon, C, Vianello, L, Gion, M

“…The percent free PSA value is a promising diagnostic tool for prostate cancer. However, its actual role has not yet been established because of the widely…”
Get more information

Relationship between cytosol TPS, TPA and cell proliferation by Gion, M, Mione, R, Becciolini, A, Balzi, M, Correale, M, Piffanelli, A, Giovannini, G, Saccani Jotti, G, Fontanesi, M

“…The serological tumor marker tissue polypeptide antigen (TPA) and the more recently identified tissue-specific polypeptide antigen (TPS) have been reported to…”
Get more information

Preliminary evaluation of CYFRA 21-1 in lung cancer cytosol by Gion, M, Dittadi, R, Mione, R, Pagan, V, Busetto, A

Get more information

Cost/effectiveness ratio of carcinoembryonic antigen--importance of adequacy of routine requests of tumor markers by Gion, M, Rampazzo, A, Mione, R, Bruscagnin, G

“…Since 1987 we have been evaluating the cost/effectiveness ratio of tumor markers using carcinoembryonic antigen (CEA) as a leading indicator. Preliminary to…”
Get more information

Cathepsin D versus other prognostic factors in breast cancer. Results and controversies of a multicenter study on 2575 cases by Pelizzola, D, Gion, M, Paradiso, A, Dittadi, R, Correale, M, Mione, R, Piffanelli, A

“…The aim of this study was the survey of cathepsin D determination in a large group of patients enrolled at several centers, under the coordination of the…”
Get more information

Relationship between prostatic acid phosphatase and prostate-specific antigen serum levels and prostatic volume in benign prostate hyperplasia. Pitfall on tumor markers assessment in primary prostatic cancer? by Omacini, S, Mione, R, Barichello, M, Santucci Delli Ponti, U, Bolgan, A, Contemori, G P, Petracco, S, Capitanio, G, Donisi, P M, Gion, M

“…Serum levels of prostatic acid phosphatase (PAP) and prostate-specific antigen (PSA) were measured in 78 patients with benign prostate hyperplasia and compared…”
Get more information

The correlation between serum levels of cytokeratin tumor markers does reflect their molecular characterization by Gion, M, Mione, R, Barioli, P, Sartorello, P, Dal Zennaro, E, Gasparini, C, Marconato, R

Get more information